SE464683B - Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e - Google Patents

Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Info

Publication number
SE464683B
SE464683B SE8403659A SE8403659A SE464683B SE 464683 B SE464683 B SE 464683B SE 8403659 A SE8403659 A SE 8403659A SE 8403659 A SE8403659 A SE 8403659A SE 464683 B SE464683 B SE 464683B
Authority
SE
Sweden
Prior art keywords
phosphate
vitamin
aica
treatment
liver
Prior art date
Application number
SE8403659A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403659D0 (sv
SE8403659L (sv
Inventor
J Schawartz
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE8403659D0 publication Critical patent/SE8403659D0/xx
Publication of SE8403659L publication Critical patent/SE8403659L/xx
Publication of SE464683B publication Critical patent/SE464683B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8403659A 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e SE464683B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU832463A HU190597B (en) 1983-07-11 1983-07-11 Process for preparing synrtgetic pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8403659D0 SE8403659D0 (sv) 1984-07-10
SE8403659L SE8403659L (sv) 1985-01-12
SE464683B true SE464683B (sv) 1991-06-03

Family

ID=10959498

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403659A SE464683B (sv) 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Country Status (11)

Country Link
US (1) US4581348A (fr)
AT (1) AT389052B (fr)
BE (1) BE900125A (fr)
CA (1) CA1238576A (fr)
CH (1) CH661866A5 (fr)
DE (1) DE3425466A1 (fr)
FR (1) FR2548900B1 (fr)
GB (1) GB2144417B (fr)
HU (1) HU190597B (fr)
IT (1) IT1214843B (fr)
SE (1) SE464683B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204097A (en) * 1977-02-25 1980-05-20 Schmit John W Lockable covering apparatus for telephone dials
US4396810A (en) * 1979-12-03 1983-08-02 Cover Hunter H Pushbutton telephone dial locks
DE3711640A1 (de) * 1987-04-07 1988-10-27 Hollingsworth Gmbh Vorrichtung zum reinigen und oeffnen von textil-fasergut
US5622991A (en) * 1994-08-30 1997-04-22 Cornell Research Foundation, Inc. Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats
CN1318029C (zh) * 1995-07-21 2007-05-30 巧妙疗法股份有限公司 氨基咪唑甲酰胺和5-氨基或取代的氨基1,2,3-三唑的盐在制备治疗和预防肿瘤的药物组合物中的用途
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
US5728707A (en) * 1995-07-21 1998-03-17 Constantia Gruppe Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
US20050220862A1 (en) 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210865B (de) * 1962-03-05 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung des 2, 6-dioxo-tetrahydropyrimidin-4-carbonsauren Salzes des 4-Amino-5-imidazolcarbonsaeureamids
US4182770A (en) * 1976-10-09 1980-01-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Alcohol deterrent
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物

Also Published As

Publication number Publication date
GB2144417B (en) 1986-10-22
SE8403659D0 (sv) 1984-07-10
IT1214843B (it) 1990-01-18
GB8417677D0 (en) 1984-08-15
HUT34122A (en) 1985-02-28
US4581348A (en) 1986-04-08
FR2548900A1 (fr) 1985-01-18
SE8403659L (sv) 1985-01-12
AT389052B (de) 1989-10-10
IT8467682A0 (it) 1984-07-04
ATA220684A (de) 1989-03-15
GB2144417A (en) 1985-03-06
DE3425466A1 (de) 1985-01-24
FR2548900B1 (fr) 1988-12-09
HU190597B (en) 1986-09-29
BE900125A (fr) 1984-11-05
CA1238576A (fr) 1988-06-28
CH661866A5 (de) 1987-08-31

Similar Documents

Publication Publication Date Title
DE60211937T2 (de) Verwendung von flibanserin bei der behandung von störungen des sexuellen verlangens
EP1378238A1 (fr) Compositions pharmaceutiques comprenant d'hydrochlorure de donepezil
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE2728685A1 (de) Arzneimittel
KR102600879B1 (ko) 세포 내 atp 증강제
CN103249417A (zh) 用于治疗高尿酸血症及相关疾病的方法
Bonati et al. Interspecies comparison of caffeine disposition
SE464683B (sv) Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e
Sioufi et al. The effect of age on the pharmacokinetics of valsartan
EP1425018B1 (fr) Preparations combinees contenant des derives de 1,4-benzothiepine-1,1-dioxyde ainsi que d'autres substances actives et utilisation desdites preparations
Weinberg et al. Modulation of cell nucleotide levels of isolated kidney tubules
CA1120400A (fr) Traitement de l'hypertension et medicaments utilises a cette fin
Kearney et al. Pharmacokinetic drug interaction and long term safety profile of tenofovir DF and lopinavir/ritonavir
EP0234464A1 (fr) Composition et méthode pour réduire la toxicité de l'acétaldéhyde
EP0278449B1 (fr) Agent modifiant la fonction rénale et diurétique et usage d'un dérivé de la benzothiazépine
LU87331A1 (fr) Orale magnesium und kalium enthaltende praeparate und deren verwendung
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
CN113425718A (zh) 一种治疗高尿酸血症和痛风的复方制剂
US7700576B2 (en) Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium
DE2555609A1 (de) Pharmazeutisches praeparat zur therapie der hyperurikaemie
Giri et al. The effect of paraquat on guanylate cyclase activity in relation to morphological changes of guinea pig lungs
CN107595848A (zh) 他达拉非口服制剂
DE3324785C2 (de) Pharmazeutische Zubereitung mit synergistischer antihypertensiver Wirkung
EP0123841B1 (fr) Médicament à activité athéroprotectrice croissante de la lipoprotéine à haute densité
EP0208962B1 (fr) Préparations combinées à partir d'inhibiteurs de l'agrégation des thrombocytes et leur application

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8403659-9

Effective date: 19930204

Format of ref document f/p: F